Pure Global

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy - Trial 2016-004958-14

Access comprehensive clinical trial information for 2016-004958-14 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Korea Inc. and is currently status unknown. The study focuses on Epilepsy.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
2016-004958-14
Trial Details
EU Clinical Trials Register โ€ข 2016-004958-14
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Study Focus

Epilepsy

Sponsor & Location

Eisai Korea Inc.

Eisai Inc.

Timeline & Enrollment

N/A

N/A

N/A

Primary Outcome

Seizure Reduction Rate

ICD-10 Classifications

Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus

Data Source

EU Clinical Trials Register

2016-004958-14

Non-Device Trial